DeviceClearance

QUANTIKINE(TM) ERYTHROPOIETIN HUMAN SERUM CONTROLS— 510(k) K931756

Substantially Equivalent

R&D Systems, Inc.

FDA 510(k) clearance K931756 for QUANTIKINE(TM) ERYTHROPOIETIN HUMAN SERUM CONTROLS, Substantially Equivalent on 1994-04-21. Applicant: R&D Systems, Inc..

Clearance details

Applicant
R&D Systems, Inc.
Product code
Code GGT
Advisory panel
Hematology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Minneapolis, MN, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.